IDEAYA Biosciences, Inc. IDYA Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s operating cash flow?
- IDEAYA Biosciences, Inc. (IDYA) reported operating cash flow of -$75.17M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s operating cash flow changed year-over-year?
- IDEAYA Biosciences, Inc.'s operating cash flow decreased by 24.6% year-over-year, from -$60.34M to -$75.17M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s operating cash flow has grown at a 6.3% compound annual growth rate (CAGR), from -$55.78M to -$71.1M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.